Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells Effect of liposomal composition Dong Il Kang et al.

Drug Delivery

Volumn 16, Issue 5, 2009, Pages 261-267

  Kang, Dong Il ^a   Kang, He Kyung ^b   Gwak, Hye Sun ^c   Han, Hyo Kyung ^d   Lim, Soo Jeong ^a  

^a Sejong University   (South Korea)

^b National Cancer Center   (South Korea)

^c Ewha Womans University   (South Korea)

^d Chosun University   (South Korea)

Author keywords

Liposomes; Multidrug resistance; P glycoprotein; Polyethyleneglycol

Indexed keywords

CHOLESTEROL; GLYCOPROTEIN P; LIPOSOME; MACROGOL; RHODAMINE 123; ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; BREAST TUMOR; CHEMISTRY; GENE EXPRESSION; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; HUMANS; LIPOSOMES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; RHODAMINE 123; RHODAMINES; TUMOR CELLS, CULTURED;

EID: 70349312396     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540902937562     Document Type: Article

References (21)

1. Advani, R., Fisher, G.A., Lum, B.L., Hausdorff, J., Halsey, J., Litchman, M., Sikic, B.I. (2001). A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance. Clin Cancer Res. 7, 1221-1229
2. Borst, P., Evers, R., Kool, M., Wijnholds, J. (2000). A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 92, 1295-1302
3. Bosch, I., Dunussi-Joannopoulos, K., Wu, R.L., Furlong, S.T., Croop, J. (1997). Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. Biochemistry. 36, 5685-5694
4. Coley, H.M. (2008). Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev. 34, 378-390
5. Eckford, P.D., Sharom, F.J. (2008). Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport. Biochemistry. 47, 13686-13698
6. Elamanchili, P., McEachern, C., Burt, H. (2008). Reversal of multidrug resistance by methoxypolyethylene glycol-block- polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function. J Pharm Sci. 98, 945-958
7. Goren, D., Horowitz, A.T., Tzemach, D., Tarshish, M., Zalipsky, S., Gabizon, A. (2000). Nuclear delivery of doxorubicin via folatetargeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res. 6, 1949-1957
8. Jabr-Milane, L.S., Van Vlerken, L.E., Yadav, S., Amiji, M.M. (2008). Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev. 34, 592-602.
9. Kono, K., Igawa, T., Takagishi, T. (1997). Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative. Biochim Biophys Acta. 1325, 143-154
10. Lee, M.K., Lim, S.J., Kim, C.K. (2007). Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials. 28, 2137-2146
11. Mamot, C., Drummond, D.C., Hong, K., Kirpotin, D.B., Park, J.W. (2003). Liposome-based approaches to overcome anticancer drug resistance. Drug Resist Updat. 6, 271-279
12. Michieli, M., Damiani, D., Ermacora, A., Masolini, P., Michelutti, A., Michelutti, T., Russo, D., Pea, F., Baccarani, M. (1999). Liposomeencapsulated daunorubicin for PGP-related multidrug resistance. Br J Haematol. 106, 92-99.
13. Mohri, M., Nitta, H., Yamashita, J. (2000). Expression of multidrug resistance-associated protein (MRP) in human gliomas. J Neurooncol. 49, 105-115
14. Romsicki, Y., Sharom, F.J. (1999). The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry. 38, 6887-6896
15. Sharom, F.J. (2008). ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 9, 105-127
16. Shukla, S., Wu, C.P., Ambudkar, S.V. (2008). Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges. Expert Opin Drug Metab Toxicol. 4, 205-223
17. Slepushkin, V.A., Simoes, S., Dazin, P., Newman, M.S., Guo, L.S., Pedroso de Lima, M.C., Duzgunes, N. (1997). Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo. J Biol Chem. 272, 2382-2388
18. Thews, O., Gassner, B., Kelleher, D.K., Gekle, M. (2008). Activity of drug efflux transporters in tumor cells under hypoxic conditions. Adv Exp Med Biol. 614, 157-164
19. Thierry, A.R., Dritschilo, A., Rahman, A. (1992). Effect of liposomes on P-glycoprotein function in multidrug resistant cells. Biochem Biophys Res Commun. 187, 1098-1105
20. Thierry, A.R., Vige, D., Coughlin, S.S., Belli, J.A., Dritschilo, A., Rahman, A. (1993). Modulation of doxorubicin resistance in multidrug- resistant cells by liposomes. FASEB J. 7, 572-579
21. Yu, G., Ahmad, S., Aquino, A., Fairchild, C.R., Trepel, J.B., Ohno, S., Suzuki, K., Tsuruo, T., Cowan, K.H., Glazer, R.I. (1991). Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun. 3, 181-189